Soleus Capital Management, L.P. Axsome Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $14.7 Million - $17.5 Million	212,600 Added 853.82%	237,500 $16.6 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $245,322 - $379,470	4,200 Added 20.29%	24,900 $1.79 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $1.71 Million - $2.2 Million	-29,300 Reduced 58.6%	20,700 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $2 Million - $3.99 Million	50,000 New	50,000 $3.86 Million

288

40.4M

365K

428K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.88B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.